Dr. Coney received his Bachelor of Science in biology from the University of Illinois and his medical degree from Loyola Stritch School of Medicine. After completing his ophthalmology residency at University Hospitals/Case Western Reserve University, where he is now a Senior Clinical Instructor, Dr. Coney finished his medical retina fellowship in diabetic retinopathy at the Joslin Diabetes Clinic of Harvard Medical School in Boston and a two-year vitreoretinal surgical fellowship at the Vitreoretinal Foundation in Memphis, Tennessee.
He is licensed to practice medicine in Ohio and Pennsylvania. Dr. Coney has served in leadership capacities for the Ophthalmology Section of the National Medical Association and the Cleveland Ophthalmological Society, and an Ambassador for the National Institutes of Health. Dr. Coney is past President and currently on the Board of Directors as well as a Counselor for the Ohio Ophthalmological Society. He is a volunteer examiner for the American Board of Ophthalmology (ABO), past member of the AAO knowledge base subcommittee- retina/vitreous panel, and currently serves on the nominating committee of the state section of the council.
He is a mentor for the American Academy of Ophthalmology Minority Ophthalmology Mentoring Program and the American Society of Retina Specialists. He is on the Diversity, Equity and Inclusion Advisory Board for the American Society of Retina Specialists and Retina World Congress and serves as an executive committee member for the National Medical Fellowship.
Dr. Coney received the 2023 Brandon Hall Award for his video on diversity, equity, and inclusion. He has been recognized amongst the top ophthalmologists in the nation by Castle Connolly and featured as a Top Doctor in Cleveland Magazine every year since 2015. He is a Vitals Patients’ Choice Award winner and has been selected by his peers for inclusion in the Best Doctors in America list of top retinal specialists.
You May Also Like
He is the principal clinical investigator for the Phase IV Elevatum clinical research trial, which is the first of its kind to address inclusivity and health determinant barriers for minorities. He is also principal investigator for other treatments for diabetic retinopathy, age-related macular degeneration (AMD), and other vitreoretinal diseases. Dr. Coney has published articles on implicit bias and patient care, how to improve diversity in the retina field, and disparities in screening and treatment of diabetic retinopathy.
He also assisted in the creation of social media content addressing social determinates of health. He is on the External Council Advancing Inclusion Research for Genentech-Roche. He volunteers his surgical talent to mentor and train ophthalmologists to become retina specialists in Haiti. Dr. Coney’s primary interests include diabetic retinopathy, AMD, traumatic eye injuries, and complex retinal surgeries including macular hole repair and macular pucker surgery.